DIGAMED develops generic drugs, dietary supplements, medical devices, and dermocosmetics under private label or the DIGAMED brand. They offer customized product development solutions including formula development, packaging, design, and registration. Their DIGAMED range is distributed across three continents through hubs in Belgium (Europe/Africa) and Panama (America). The company operates under DIGA TRADING S.A. and DIGA LATAM S.A., with leadership including CEO Raphael Elleboudt and Office Manager Véronique Diez Hofmans. Their products serve the pharmaceuticals and food supplement industry, with an emphasis on innovative and tailored formulations for clients.